Reports
Sale
Global Balloon Catheters Market Size, Share, Growth, Report: By Product: Rapid Exchange (RX) Balloon Catheters, Over-The-Wire (OTW) Balloon Catheters, Drug Eluting Balloon Catheters, Stent Graft Balloon Catheters, Others; By Indication: Coronary Artery Disease, Others; By End-user; Regional Analysis; Supplier Landscape; 2024-2032
Global Balloon Catheters Market Outlook
The global balloon catheters market size was valued at USD 4.5 billion in 2023, driven by the rising prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 6.5% during the forecast period of 2024-2032, with the values likely to rise from USD 4.8 billion in 2024 to USD 8.1 billion by 2032.
Key Takeaways
-
Cardiovascular disease (CVD) ranks as the leading cause of mortality globally, with recent data estimating that approximately 620 million individuals are affected by heart and circulatory diseases.
-
In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC. It can be used for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease.
- The rising healthcare infrastructure investments and growing demand for minimally invasive procedures are key factors elevating the balloon catheter market value.
Balloon catheters comprise an inflatable balloon at the tip which can be often used to enlarge a narrow opening during a catheterization procedure. After the inflated balloon performs the procedure, it is deflated to remove it from the body. Balloon catheters with over-the-wire (OTW) or rapid exchange (Rx) designs are often employed during angioplasty procedures.
Balloon catheters are considered pivotal in revolutionizing minimally invasive procedures. As a result, it is experiencing high demand in the market for various medical procedures, including angioplasty and stenting. The market holds high value which can be attributed to the rising prevalence of cardiovascular diseases, growing geriatric population, and the increased adoption of technologically advanced balloon catheter technologies.
Global Balloon Catheters Market Trends
The rising technological advancement, miniaturization of devices, increased application of balloon catheters in minimally invasive procedures, and the growing geriatric population comprise some of the key trends and developments in the market.
| Date | Company | Event |
| December 2023 | HR Pharmaceuticals, Inc. | HR Pharmaceuticals, Inc. (HRP) announced that it has signed an Exclusive Commercial Agreement with Poiesis Medical LLC, which grants HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. The dual balloon catheter technology is expected to provide better results than conventional Foley catheters. With this new addition to its urological portfolio, the company aims to improve patient outcomes and drive balloon catheters market growth. |
| December 2023 | Summa Therapeutics, LLC | The United States Food and Drug Administration (FDA) has granted approval to the Finesse Injectable angioplasty balloon catheters developed by a United States-based medical devices company, Summa Therapeutics, LLC, for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease including popliteal, iliac, femoral, and renal arteries, among others. The Finesse product line offers a port to inject radiopaque contrast material along with its role in performing balloon angioplasty, thus acting as an advanced toolset for angioplasty procedures. |
| June 2023 | Translumina Therapeutics | A leading interventional cardiovascular device company, Translumina Therapeutics, acquired Blue Medical Devices, a Netherlands-based medical technology manufacturer. Through this acquisition, the company expanded its intervention cardiology portfolio with Blue Medical’s next-generation Drug Coated Balloon Catheters, which will complement its next-generation drug eluting stents product line. The increasing incidence of such strategic collaborations is poised to boost the balloon catheters market share in coming years. |
| May 2023 | Concept Medical Inc. | Concept Medical Inc. received an Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for its novel MagicTouch Sirolimus Coated Balloon (SCB) Catheter to treat small coronary artery disease. The approval will allow the company to test the effectiveness and safety of the device in treating the condition through appropriate clinical studies. The data generated from the trials will further help in submitting a pre-market approval (PMA) application in the United States. |
| Key Trend | Impact |
| Rising Technological Advancement | The integration of advanced imaging technologies and pressure sensors within balloon catheters facilitates real-time feedback and precision during procedures. The demand for smart catheters is expected to rise as they improve procedural success rates, enhance safety, and offer more personalized treatments. |
| Miniaturization of Devices | The development of smaller and more flexible balloon catheters has enabled access to challenging vascular regions. This miniaturization reduces procedural risks as well as recovery times and is likely to fuel the balloon catheter market demand in the coming years. |
| Increased Application in Minimally Invasive Procedures | With the patient’s inclination towards minimally invasive surgical techniques, there is a rising demand for balloon catheters across various medical procedures, including angioplasty and stenting. Thus, balloon catheters play an important role in reducing surgical trauma and improving patient recovery. |
| Growth in Geriatric Population | The rising geriatric population, more susceptible to cardiovascular and peripheral vascular diseases, directly influences the demand for balloon catheter-based interventions. This shift necessitates the availability and development of innovative balloon catheter devices. |
Global Balloon Catheters Market Growth Factors
The market is driven by the surge in novel product approvals by health regulatory agencies such as the United States Food and Drug Administration (FDA). The accelerated regulatory approvals for balloon catheter products foster accessibility and subsequent adoption of these advanced technologies in the healthcare sector. Moreover, it encourages health technology companies to invest significantly in the development of such products, which is expected to boost the balloon catheter market size.
The increased strategic partnerships among the key market players, rising healthcare spending, and heightened public awareness about cardiovascular health are likely to augment the market size for balloon catheters. Moreover, increased innovations in the material technology of balloon catheters such as the use of advanced polymers are also expected to drive market growth in the forecast period.
Global Balloon Catheters Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Rapid Exchange (RX) Balloon Catheters, Over-The-Wire (OTW) Balloon Catheters, Drug Eluting Balloon Catheters, Stent Graft Balloon Catheters, Others |
| Indication | Coronary Artery Disease, Peripheral Vascular Disease |
| End User | Hospitals, Ambulatory Surgical Centers, Others |
| Region | North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
By product, the market includes rapid exchange (RX) balloon catheters, over-the-wire (OTW) balloon catheters, drug eluting balloon catheters, and stent graft balloon catheters, among others. The demand for balloon catheters is expected to rise owing to the rising prevalence of chronic heart diseases and increased healthcare expenditure.
In terms of indication, balloon catheters are utilized primarily in the treatment of coronary artery disease and peripheral vascular disease. These devices help in addressing blockages and narrowing of blood vessels in the heart and peripheral arteries.
By end users, the balloon catheters market share includes hospitals, ambulatory surgical centers, and other healthcare facilities where interventional procedures are performed for patients with cardiovascular conditions.
On the basis of region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Regional disparities exist in the markets depending on variables such as healthcare infrastructure, the prevalence of cardiovascular diseases, and the regulatory framework in the region.
Global Balloon Catheters Market: Competitive Landscape
The key market players are contributing to the balloon catheters market growth through innovative product launches, increased investments, and continuous research and development initiatives aimed at technological advancement.
| Company | Year Founded | Headquarters | Products/Services |
| Medtronic | 1949 | Dublin, Ireland | Offers a wide range of balloon catheters for cardiovascular procedures |
| Boston Scientific Corporation | 1979 | Marlborough, Massachusetts, USA | Specializes in innovative balloon catheters for coronary interventions |
| Abbott | 1888 | Abbott Park, Illinois, USA | Provides various balloon catheter products for cardiovascular treatments and interventions. |
| Spectrum Plastics Group | 1949 | Alpharetta, Georgia, USA | Manufactures advanced medical tubing extrusions and catheter components |
Other key players in the market include Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc, B. Braun SE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology (Beijing) Co., Ltd., and INVAMED.
Global Balloon Catheters Market Analysis by Region
North America holds a significant share of the market which can be attributed to the presence of an advanced healthcare system and increased demand for minimally invasive interventions. Further, the rising elderly population with a high risk of having heart and circulatory conditions, the surge in product approvals by regulatory bodies, and robust research and development initiatives are some of the factors that are expected to boost market growth in the forecast period.
In Europe, the balloon catheter market size is experiencing a steady expansion due to the rising prevalence of cardiovascular diseases in the region. It is estimated that around 45% of mortality in Europe is caused by cardiovascular diseases, which indicates the need for appropriate interventions such as advanced balloon catheter technology to tackle the rising disease burden. Moreover, the presence of leading marketing players and premium research institutes directly impacts the market dynamics in this regional market.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Indication |
|
| Breakup by End-user |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Balloon Catheters Market Overview
3.1 Global Balloon Catheters Market Historical Value (2017-2023)
3.2 Global Balloon Catheters Market Forecast Value (2024-2032)
4 Global Balloon Catheters Market Landscape*
4.1 Global Balloon Catheters Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Balloon Catheters Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Indication
4.2.3 Analysis by Raw Material
5 Global Balloon Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Balloon Catheters Market Segmentation (2017-2032)
6.1 Global Balloon Catheters Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Rapid Exchange (RX) Balloon Catheters
6.1.3 Over-The-Wire (OTW) Balloon Catheters
6.1.4 Drug Eluting Balloon Catheters
6.1.5 Stent Graft Balloon Catheters
6.1.6 Others
6.2 Global Balloon Catheters Market (2017-2032) by Indication
6.2.1 Market Overview
6.2.2 Coronary Artery Disease
6.2.3 Peripheral Vascular Disease
6.3 Global Balloon Catheters Market (2017-2032) by End-user
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centers
6.3.4 Others
6.4 Global Balloon Catheters Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Balloon Catheters Market (2017-2032)
7.1 North America Balloon Catheters Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Rapid Exchange (RX) Balloon Catheters
7.1.3 Over-The-Wire (OTW) Balloon Catheters
7.1.4 Drug Eluting Balloon Catheters
7.1.5 Stent Graft Balloon Catheters
7.1.6 Others
7.2 North America Balloon Catheters Market (2017-2032) by Indication
7.2.1 Coronary Artery Disease
7.2.2 Peripheral Vascular Disease
7.3 North America Balloon Catheters Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Balloon Catheters Market (2017-2032)
8.1 Europe Balloon Catheters Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Rapid Exchange (RX) Balloon Catheters
8.1.3 Over-The-Wire (OTW) Balloon Catheters
8.1.4 Drug Eluting Balloon Catheters
8.1.5 Stent Graft Balloon Catheters
8.1.6 Others
8.2 Europe Balloon Catheters Market (2017-2032) by Indication
8.2.1 Coronary Artery Disease
8.2.2 Peripheral Vascular Disease
8.3 Europe Balloon Catheters Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Balloon Catheters Market (2017-2032)
9.1 Asia Pacific Balloon Catheters Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Rapid Exchange (RX) Balloon Catheters
9.1.3 Over-The-Wire (OTW) Balloon Catheters
9.1.4 Drug Eluting Balloon Catheters
9.1.5 Stent Graft Balloon Catheters
9.1.6 Others
9.2 Asia Pacific Balloon Catheters Market (2017-2032) by Indication
9.2.1 Coronary Artery Disease
9.2.2 Peripheral Vascular Disease
9.3 Asia Pacific Balloon Catheters Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Balloon Catheters Market (2017-2032)
10.1 Latin America Balloon Catheters Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Rapid Exchange (RX) Balloon Catheters
10.1.3 Over-The-Wire (OTW) Balloon Catheters
10.1.4 Drug Eluting Balloon Catheters
10.1.5 Stent Graft Balloon Catheters
10.1.6 Others
10.2 Latin America Balloon Catheters Market (2017-2032) by Indication
10.2.1 Coronary Artery Disease
10.2.2 Peripheral Vascular Disease
10.3 Latin America Balloon Catheters Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Balloon Catheters Market (2017-2032)
11.1 Middle East and Africa Balloon Catheters Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Rapid Exchange (RX) Balloon Catheters
11.1.3 Over-The-Wire (OTW) Balloon Catheters
11.1.4 Drug Eluting Balloon Catheters
11.1.5 Stent Graft Balloon Catheters
11.1.6 Others
11.2 Middle East and Africa Balloon Catheters Market (2017-2032) by Indication
11.2.1 Coronary Artery Disease
11.2.2 Peripheral Vascular Disease
11.3 Middle East and Africa Balloon Catheters Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Abbott
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Spectrum Plastics Group
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Biotronik
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Shanghai MicroPort Medical (Group) Co., Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Artivion, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 B. Braun SE
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cook Group Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Becton, Dickinson and Company
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Cardinal Health
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Terumo Medical Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Coloplast Group
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Lepu Medical Technology (Beijing)Co.,Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 INVAMED
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Balloon Catheters Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 4.5 billion in 2023 driven by the rising prevalence of cardiovascular diseases across the globe.
The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032, likely to reach a market value of USD 8.1 billion by 2032.
Advancements in balloon catheter technology and rising healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is the increased merger and acquisition initiatives among the key market players. In June 2023, Translumina Therapeutics, acquired a Blue Medical Devices (Netherlands-based medical technology manufacturer) to expand its intervention cardiology portfolio with Blue Medical’s next-generation drug coated balloon catheters.
Based on the product, the market is segmented into rapid exchange (RX) balloon catheters, over-the-wire (OTW) balloon catheters, drug eluting balloon catheters, and stent graft balloon catheters, among others.
Major end users include hospitals and ambulatory surgical centers, among others.
Based on indication, the market includes coronary artery disease and peripheral vascular disease.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Medtronic, Boston Scientific Corporation, Abbott, Spectrum Plastics Group, Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc, B. BraunSE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology (Beijing) Co., Ltd., and INVAMED.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER